Toyama, Japan

Hisanari Shibata

This inventor holds 4 USPTO granted patents. Top assignee: Toyama Chemical Co., Ltd.. Active years: 1987-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hisanari Shibata. Retrieved from https://idiyas.com/inventor/hisanari-shibata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1987-1992

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hisanari Shibata: Innovator in Amine Derivatives

Introduction

Hisanari Shibata is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of amine derivatives. With a total of 4 patents to his name, Shibata's work has implications for both human and animal health.

Latest Patents

Shibata's latest patents focus on amine derivatives and their salts, which exhibit anti-ulcer activity. These compounds are designed to be effective for both humans and animals. His inventions include a detailed process for preparing these compounds, as well as an anti-ulcer agent that incorporates them. This innovative work highlights the potential therapeutic applications of amine derivatives in medical treatments.

Career Highlights

Throughout his career, Shibata has been associated with Toyama Chemical Co., Ltd., where he has contributed to various research initiatives. His expertise in chemistry and dedication to innovation have positioned him as a key figure in his field.

Collaborations

Shibata has worked alongside talented colleagues such as Shiro Hirai and Hiroshi Hirano. Their collaborative efforts have further advanced the research and development of new chemical compounds.

Conclusion

Hisanari Shibata's contributions to the field of chemistry, particularly through his patents on amine derivatives, demonstrate his commitment to innovation and improving health outcomes. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…